Evidence map›Paper›PMID 38842631›Full record

ArticleWorld journal of microbiology & biotechnology2024

AcrAB-TolC efflux pump overexpression and tet(A) gene mutation increase tigecycline resistance in Klebsiella pneumoniae.

Zhaoxin Xia, Jing Zhou, Nana Gao, Ge Li, Runde Liu, Guoping Lu, Jilu Shen

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Acquisition and Transmission ofInfection and drug resistance · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhaoxin XiaDepartment of Clinical Laboratory, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Jing ZhouDepartment of Clinical Laboratory, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Nana GaoDepartment of Clinical Laboratory, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Ge LiDepartment of Clinical Laboratory, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Runde LiuDepartment of Clinical Laboratory, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Guoping LuAnhui Medical University Affiliated Fuyang Hospital, Fuyang, 236000, Anhui, China.
Jilu ShenDepartment of Clinical Laboratory, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. shenjilu@ahmu.edu.cn.

Funding

2020 Anhui Provincial University Cooperative Research and Public Health Collaborative Innovation Project of Anhui Provincial Department of Education GXXT-2020-0162021 Anhui Provincial Key Project of Natural Science Research in Colleges and Universities KJ2021ZD0032Anhui Medical University 2022xkj215Scientific Research Project of Fuyang City Health Commission FY2021-130
6 · The paper itself

Abstract

Tigecycline-non-susceptible Klebsiella pneumoniae (TNSKP) is increasing and has emerged as a global public health issue. However, the mechanism of tigecycline resistance remains unclear. The objective of this study was to investigate the potential role of efflux pump system in tigecycline resistance. 29 tigecycline-non-susceptible Klebsiella pneumoniae (TNSKP) strains were collected and their minimum inhibitory concentrations (MIC) were determined by the broth microdilution method. The ramR, acrR, rpsJ, tet(A), and tet(X) were amplified by polymerase chain reaction (PCR). The mRNA expression of different efflux pump genes and regulator genes were analyzed by real-time PCR. Additionally, KP14 was selected for genome sequencing. KP14 genes without acrB, oqxB, and TetA were modified using suicide plasmids and MIC of tigecycline of KP14 with target genes knocked out was investigated. It was found that MIC of tigecycline of 20 out of the 29 TNSKP strains decreased by over four folds once combined with phenyl-arginine-β-naphthylamide dihydrochloride (PaβN). Most strains exhibited upregulation of AcrAB and oqxAB efflux pumps. The strains with acrB, oqxB, and tetA genes knocked out were constructed, wherein the MIC of tigecycline of KP14∆acrB and KP14∆tetA was observed to be 2 µg/mL (decreased by 16 folds), the MIC of tigecycline of KP14ΔacrBΔTetA was 0.25 µg/mL (decreased by 128 folds), but the MIC of tigecycline of KP14∆oqxB remained unchanged at 32 µg/mL. The majority of TNSKP strains demonstrated increased expression of AcrAB-TolC and oqxAB, while certain strains showed mutations in other genes associated with tigecycline resistance. In KP14, both overexpression of AcrAB-TolC and tet(A) gene mutation contributed to the mechanism of tigecycline resistance.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsKlebsiella pneumoniaeMicrobial Sensitivity TestsMutationTigecyclineAntiportersDrug Resistance, BacterialGene Expression Regulation, BacterialHumansMembrane Transport ProteinsAnti-Bacterial AgentsAntiportersBacterial ProteinsMembrane Transport ProteinstetA protein, BacteriaTigecyclineEfflux pumpKlebsiella pneumoniaeResistance mechanismTigecycline

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.